These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 10850384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB, Hollinger FB.
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, Hollinger FB, Hathcote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J.
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [Abstract] [Full Text] [Related]

  • 4. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
    Keeffe EB, Dusheiko GM, Tong MJ, Hollinger FB, Heathcote EJ, McHutchison J, Albert D.
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
    Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX.
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP.
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
    Everson GT, Jensen DM, Craig JR, van Leeuwen DJ, Bain VG, Ehrinpreis MN, Albert D, Joh T, Witt K.
    Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S.
    Hepatogastroenterology; 2002 Jul; 49(47):1373-6. PubMed ID: 12239945
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ, Lee SD, Chan CY, Lu RH, Chang FY.
    Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
    [Abstract] [Full Text] [Related]

  • 15. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 16. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
    Heathcote EJ, James S, Mullen KD, Hauser SC, Rosenblate H, Albert DG.
    Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669
    [Abstract] [Full Text] [Related]

  • 17. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.
    N Engl J Med; 1998 Nov 19; 339(21):1485-92. PubMed ID: 9819446
    [Abstract] [Full Text] [Related]

  • 18. Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.
    Spiliopoulou I, Repanti M, Katinakis S, Karana-Ginopoulou A, Papanastasiou DA.
    Eur J Clin Microbiol Infect Dis; 1999 Oct 19; 18(10):709-15. PubMed ID: 10584897
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Akuta N, Someya T, Kumada H.
    J Gastroenterol; 2003 Oct 19; 38(2):158-63. PubMed ID: 12640530
    [Abstract] [Full Text] [Related]

  • 20. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis.
    Yu ML, Wang LY, Chuang WL, Dai CY, Sung MH, Chen SC, Lin ZY, Hsieh MY, Tsai JF, Chang WY.
    J Gastroenterol Hepatol; 2000 Jul 19; 15(7):792-7. PubMed ID: 10937687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.